Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 14, Pages 10124-10138
Publisher
American Chemical Society (ACS)
Online
2021-07-02
DOI
10.1021/acs.jmedchem.1c00360
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease
- (2020) Luiza M.F. Gomes et al. COORDINATION CHEMISTRY REVIEWS
- Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions
- (2020) Gideon K. Yawson et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- Inhibition of Amyloid-β Aggregation by Cobalt(III) Schiff Base Complexes: A Computational and Experimental Approach
- (2019) Aysenur Iscen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
- (2019) Luiza M. F. Gomes et al. Frontiers in Chemistry
- Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex
- (2018) Giyeong Son et al. Acta Biomaterialia
- Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)–Platinum(II) Polypyridyl Complexes
- (2018) Nilima A. Vyas et al. INORGANIC CHEMISTRY
- Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
- (2018) Paul A. Adlard et al. JOURNAL OF ALZHEIMERS DISEASE
- Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
- (2017) Rui Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Mechanistic Insights into Tunable Metal-Mediated Hydrolysis of Amyloid-β Peptides
- (2017) Jeffrey S. Derrick et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Photochemical Identification of Molecular Binding Sites on the Surface of Amyloid-β Fibrillar Aggregates
- (2017) Amir Aliyan et al. Chem
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment.
- (2017) N. R. Dickson et al. JOURNAL OF CLINICAL ONCOLOGY
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- BDDCS, the Rule of 5 and drugability
- (2016) Leslie Z. Benet et al. ADVANCED DRUG DELIVERY REVIEWS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity
- (2016) Stephanie. W. Chang et al. INORGANIC CHEMISTRY
- X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
- (2016) Aleksandar Bijelic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Interpreting the Paramagnetic NMR Spectra of Potential Ru(III) Metallodrugs: Synergy between Experiment and Relativistic DFT Calculations
- (2016) Jan Novotný et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- pyridylmethyl)amine (tpa) as an Inhibitor of Beta-Amyloid Fibrillation
- (2015) Sharon Chan et al. Current Alzheimer Research
- Albumin binding and ligand-exchange processes of the Ru(iii) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy
- (2015) Michael I. Webb et al. DALTON TRANSACTIONS
- Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
- (2015) Michael R. Jones et al. Metallomics
- Methionine oxidation of amyloid peptides by peroxovanadium complexes: inhibition of fibril formation through a distinct mechanism
- (2015) Lei He et al. Metallomics
- Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
- (2015) Sergio T. Ferreira et al. Frontiers in Cellular Neuroscience
- Modulation of Amyloid-β Aggregation by Histidine-Coordinating Cobalt(III) Schiff Base Complexes
- (2014) Marie C. Heffern et al. CHEMBIOCHEM
- Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation
- (2014) Nilima A. Vyas et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of 2-Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid-β Aggregation and Neurotoxicity Evaluation
- (2014) Gorakh S. Yellol et al. INORGANIC CHEMISTRY
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- Chiral Metallohelical Complexes Enantioselectively Target Amyloid β for Treating Alzheimer’s Disease
- (2014) Meng Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Development of a Platinum Complex as an anti-Amyloid Agent for the Therapy of Alzheimer’s Disease
- (2013) Vijaya B. Kenche et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide
- (2013) Victor A. Streltsov et al. CHEMICAL COMMUNICATIONS
- Increasing the Bioavailability of RuIIIAnticancer Complexes through Hydrophobic Albumin Interactions
- (2013) Michael I. Webb et al. CHEMISTRY-A EUROPEAN JOURNAL
- EPR as a probe of the intracellular speciation of ruthenium(iii) anticancer compounds
- (2013) Michael I. Webb et al. Metallomics
- Simultaneous Measurement of Amyloid Fibril Formation by Dynamic Light Scattering and Fluorescence Reveals Complex Aggregation Kinetics
- (2013) Aaron M. Streets et al. PLoS One
- Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex
- (2013) Luigi Messori et al. ACS Medicinal Chemistry Letters
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- Facile Methodology for Monitoring Amyloid-β Fibrillization
- (2012) Nathan P. Cook et al. ACS Chemical Neuroscience
- NMR Solution Structure of Rat Aβ(1–16): Toward Understanding the Mechanism of Rats' Resistance to Alzheimer's Disease
- (2012) Andrey N. Istrate et al. BIOPHYSICAL JOURNAL
- Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases
- (2012) John H. Viles COORDINATION CHEMISTRY REVIEWS
- Influence of bromoethyl group on biological activity of 5-fluorouracil prodrug: Insights from X-ray crystallography and molecular docking
- (2012) Xian-Chuan Li et al. JOURNAL OF MOLECULAR STRUCTURE
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- Identification of [PtCl2(phen)] Binding Modes in Amyloid-β Peptide and the Mechanism of Aggregation Inhibition
- (2011) Guolin Ma et al. CHEMISTRY-A EUROPEAN JOURNAL
- Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(iii) complex NAMI-A by interactions with human serum albumin
- (2011) Michael I. Webb et al. DALTON TRANSACTIONS
- Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
- (2011) Michael I. Webb et al. INORGANIC CHEMISTRY
- A DFT STUDY ON THE HYDROLYSIS MECHANISM OF THE NAMI-A-TYPE ANTITUMOR COMPLEX (HL)[trans-RUCl4L(dmso-S)](L=4-amino-1,2,4-triazole)
- (2011) LAN MEI CHEN et al. JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY
- Group 9 metal-based inhibitors of β-amyloid (1–40) fibrillation as potential therapeutic agents for Alzheimer's disease
- (2011) Bradley Yat-Wah Man et al. Chemical Science
- Inhibition of Aβ42 Peptide Aggregation by a Binuclear Ruthenium(II)−Platinum(II) Complex: Potential for Multimetal Organometallics as Anti-amyloid Agents
- (2010) Amit Kumar et al. ACS Chemical Neuroscience
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
- (2010) Travis T. Wager et al. ACS Chemical Neuroscience
- fac-{Ru(CO)3}2+Selectively Targets the Histidine Residues of the β-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes
- (2010) Daniela Valensin et al. INORGANIC CHEMISTRY
- Preparation and characterization of toxic Aβ aggregates for structural and functional studies in Alzheimer's disease research
- (2010) Asad Jan et al. Nature Protocols
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- Metals in Alzheimer's and Parkinson's Diseases
- (2008) Kevin J Barnham et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Platinum-based inhibitors of amyloid- as therapeutic agents for Alzheimer's disease
- (2008) K. J. Barnham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More